Antibiotice Iasi Aims to Invest RON850M by 2030
<img src="http://storage0.dms.mpinteractiv.ro/media/401/1561/19649/22502626/1/sebastian-costea-atb.jpg?width=160&height=120"/> Romanian drug manufacturer Antibiotice Iasi has a RON850 million investment plan until 2030, covered through a funding mix, made up of cohesion funds, state aid, PNRR funds and EIB loan, stated Sebastian Costea, executive manager for sustainability and strategic investments at the company.
														<br/><br/><a href="https://core.adservingfactory.com/click?spgid=0&__x1ts=&pub=62&site=4268&section=0&zone=2008&size=0x0&__x1cguid=997">
					<img src="https://core.adservingfactory.com/ad?__x1ns=1&spgid=0&pub=632203491294404&site=rss.zf&section=site&zone=RSS_feed&size=300x250&__x1cguid=997" border="0" alt=""/>
					</a>